Quoin Pharmaceuticals, Ltd. (QNRX)

Every figure this model derived for QNRX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2021-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 103,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2020-12-31
cash 10,800,082 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 11,636,228 AssetsCurrent 2026-06-30
current liabilities 6,613,158 LiabilitiesCurrent 2026-06-30
equity 3,932,671 StockholdersEquity 2026-06-30
interest expense 1,090,409 InterestExpense 2021-12-31
revenue 0 RevenueFromContractWithCustomerExcludingAssessedTax 2021-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up QNRX on one particular measure came for.

RatioValue
current ratio1.76
current ratio reported1.76
dilution pct31.94
interest cover-3.99

What to be careful about

What this model itself distrusts about QNRX's figures. Written by the derivation as it ran, not added afterwards.